Wendy Chu

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Mondal, Dinesh et al.

Part of Clinical Pharmacology and Therapeutics, p. 437-446, 2026

• DOI for Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
• Download full text (pdf) of Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Pandey, Krishna et al.

Part of International Journal of Antimicrobial Agents, 2026

• DOI for Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis
• Download full text (pdf) of Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Chu, Wan-Yu; Fahal, Ahmed H; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak et al.

Part of Journal of Infectious Diseases, 2025

• DOI for Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma
• Download full text (pdf) of Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Chu, Wan-Yu; Schouten, Wietse M.; Mavoko, Hypolite Muhindo; Tshiongo, Japhet Kabalu et al.

Part of Clinical Pharmacokinetics, p. 1855-1867, 2025

• DOI for Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study
• Download full text (pdf) of Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Dorlo, Thomas P. C.; Chu, Wan-Yu

Part of Journal of Antimicrobial Chemotherapy, p. 1162-1164, 2025

• DOI for Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Mondal, Dinesh et al.

Part of Clinical Pharmacology and Therapeutics, p. 437-446, 2026

• DOI for Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
• Download full text (pdf) of Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Pandey, Krishna et al.

Part of International Journal of Antimicrobial Agents, 2026

• DOI for Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis
• Download full text (pdf) of Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Chu, Wan-Yu; Fahal, Ahmed H; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak et al.

Part of Journal of Infectious Diseases, 2025

• DOI for Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma
• Download full text (pdf) of Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Chu, Wan-Yu; Schouten, Wietse M.; Mavoko, Hypolite Muhindo; Tshiongo, Japhet Kabalu et al.

Part of Clinical Pharmacokinetics, p. 1855-1867, 2025

• DOI for Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study
• Download full text (pdf) of Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Dorlo, Thomas P. C.; Chu, Wan-Yu

Part of Journal of Antimicrobial Chemotherapy, p. 1162-1164, 2025

• DOI for Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

Palic, Semra; Chu, Wan-Yu; Sundar, Shyam; Mondal, Dinesh et al.

Part of Journal of Antimicrobial Chemotherapy, p. 1547-1554, 2024

• DOI for Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
• Download full text (pdf) of Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

Chu, Wan-Yu; Verrest, Luka; Younis, Brima M; Musa, Ahmed M et al.

Part of Journal of Infectious Diseases, 2024

• DOI for Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa
• Download full text (pdf) of Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Fahal, Ahmed H.; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak; Bakhiet, Osama Elhadi et al.

Part of The Lancet - Infectious diseases, p. 1254-1265, 2024

• DOI for Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

Chu, Wan-Yu; Nijman, Maaike; Stegeman, Raymond; Breur, Johannes M. P. J. et al.

Part of Clinical Pharmacokinetics, p. 1205-1220, 2024

• DOI for Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease
• Download full text (pdf) of Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

Verrest, Luka; Monnerat, Severine; Musa, Ahmed M.; Mbui, Jane et al.

Part of PLoS Neglected Tropical Diseases, 2024

• DOI for Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model
• Download full text (pdf) of Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

Verrest, Luka; Roseboom, Ignace C.; Wasunna, Monique; Mbui, Jane et al.

Part of Journal of Antimicrobial Chemotherapy, p. 2702-2714, 2023

• DOI for Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
• Download full text (pdf) of Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

Comment on "Dosing implications for liposomal amphotericin B in pregnancy"

Chu, Wan-Yu; Dorlo, Thomas P. C.

Part of Pharmacotherapy, p. 991-991, 2023

• DOI for Comment on "Dosing implications for liposomal amphotericin B in pregnancy"